Eikon Therapeutics $381 million IPO
We advised the representatives of the several underwriters on the IPO
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Maze Therapeutics $200 million at-the-market offering
We advised the sales agent on the offering
Victory for Nextpower in $48.5 million breach of contract action
We secured a complete dismissal of all claims in Delaware Chancery Court
Kodiak Sciences $184 million stock offering
We advised the underwriters on the offering
Tenaya Therapeutics $60 million units offering
We advised the joint book-running managers and representatives of the several underwriters
Denali Therapeutics $200 million stock and pre-funded warrants offering
We advised the representatives of the several underwriters on the offering
Fastly $160 million convertible senior notes offering
We advised the representatives of the several initial purchasers on the offering
Illumina $500 million notes offering
We advised the underwriters on the offering
Equinix C$700 million debut Canadian dollar notes offering
We advised Equinix on the investment-grade offering
Ionis Pharmaceuticals $770 million convertible senior notes offering
We advised the representatives of the initial purchasers on the offering